miR-22 suppresses DNA ligase III addiction in multiple myeloma

Daniele Caracciolo, Maria Teresa Di Martino, Nicola Amodio, Eugenio Morelli, Martina Montesano, Cirino Botta, Francesca Scionti, Daniela Talarico, Emanuela Altomare, Maria Eugenia Gallo Cantafio, Valeria Zuccalà, Lorenza Maltese, Katia Todoerti, Marco Rossi, Mariamena Arbitrio, Antonino Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Multiple myeloma (MM) is a hematologic malignancy characterized by high genomic instability. Here we provide evidence that hyper-activation of DNA ligase III (LIG3) is crucial for genomic instability and survival of MM cells. LIG3 mRNA expression in MM patients correlates with shorter survival and even increases with more advanced stage of disease. Knockdown of LIG3 impairs MM cells viability in vitro and in vivo, suggesting that neoplastic plasmacells are dependent on LIG3-driven repair. To investigate the mechanisms involved in LIG3 expression, we investigated the post-transcriptional regulation. We identified miR-22-3p as effective negative regulator of LIG3 in MM. Enforced expression of miR-22 in MM cells downregulated LIG3 protein, which in turn increased DNA damage inhibiting in vitro and in vivo cell growth. Taken together, our findings demonstrate that myeloma cells are addicted to LIG3, which can be effectively inhibited by miR-22, promoting a novel axis of genome stability regulation.

Original languageEnglish
Pages (from-to)487-498
JournalLeukemia
Volume33
Issue number2
DOIs
Publication statusPublished - 2019

Fingerprint

Multiple Myeloma
Genomic Instability
Survival
Hematologic Neoplasms
DNA Damage
DNA Ligase ATP
Cell Survival
Down-Regulation
Messenger RNA
Growth
Proteins

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Caracciolo, D., Di Martino, M. T., Amodio, N., Morelli, E., Montesano, M., Botta, C., ... Tassone, P. (2019). miR-22 suppresses DNA ligase III addiction in multiple myeloma. Leukemia, 33(2), 487-498. https://doi.org/10.1038/s41375-018-0238-2

miR-22 suppresses DNA ligase III addiction in multiple myeloma. / Caracciolo, Daniele; Di Martino, Maria Teresa; Amodio, Nicola; Morelli, Eugenio; Montesano, Martina; Botta, Cirino; Scionti, Francesca; Talarico, Daniela; Altomare, Emanuela; Gallo Cantafio, Maria Eugenia; Zuccalà, Valeria; Maltese, Lorenza; Todoerti, Katia; Rossi, Marco; Arbitrio, Mariamena; Neri, Antonino; Tagliaferri, Pierosandro; Tassone, Pierfrancesco.

In: Leukemia, Vol. 33, No. 2, 2019, p. 487-498.

Research output: Contribution to journalArticle

Caracciolo, D, Di Martino, MT, Amodio, N, Morelli, E, Montesano, M, Botta, C, Scionti, F, Talarico, D, Altomare, E, Gallo Cantafio, ME, Zuccalà, V, Maltese, L, Todoerti, K, Rossi, M, Arbitrio, M, Neri, A, Tagliaferri, P & Tassone, P 2019, 'miR-22 suppresses DNA ligase III addiction in multiple myeloma', Leukemia, vol. 33, no. 2, pp. 487-498. https://doi.org/10.1038/s41375-018-0238-2
Caracciolo D, Di Martino MT, Amodio N, Morelli E, Montesano M, Botta C et al. miR-22 suppresses DNA ligase III addiction in multiple myeloma. Leukemia. 2019;33(2):487-498. https://doi.org/10.1038/s41375-018-0238-2
Caracciolo, Daniele ; Di Martino, Maria Teresa ; Amodio, Nicola ; Morelli, Eugenio ; Montesano, Martina ; Botta, Cirino ; Scionti, Francesca ; Talarico, Daniela ; Altomare, Emanuela ; Gallo Cantafio, Maria Eugenia ; Zuccalà, Valeria ; Maltese, Lorenza ; Todoerti, Katia ; Rossi, Marco ; Arbitrio, Mariamena ; Neri, Antonino ; Tagliaferri, Pierosandro ; Tassone, Pierfrancesco. / miR-22 suppresses DNA ligase III addiction in multiple myeloma. In: Leukemia. 2019 ; Vol. 33, No. 2. pp. 487-498.
@article{56b870a3f9d04cb583ab1b678301c978,
title = "miR-22 suppresses DNA ligase III addiction in multiple myeloma",
abstract = "Multiple myeloma (MM) is a hematologic malignancy characterized by high genomic instability. Here we provide evidence that hyper-activation of DNA ligase III (LIG3) is crucial for genomic instability and survival of MM cells. LIG3 mRNA expression in MM patients correlates with shorter survival and even increases with more advanced stage of disease. Knockdown of LIG3 impairs MM cells viability in vitro and in vivo, suggesting that neoplastic plasmacells are dependent on LIG3-driven repair. To investigate the mechanisms involved in LIG3 expression, we investigated the post-transcriptional regulation. We identified miR-22-3p as effective negative regulator of LIG3 in MM. Enforced expression of miR-22 in MM cells downregulated LIG3 protein, which in turn increased DNA damage inhibiting in vitro and in vivo cell growth. Taken together, our findings demonstrate that myeloma cells are addicted to LIG3, which can be effectively inhibited by miR-22, promoting a novel axis of genome stability regulation.",
author = "Daniele Caracciolo and {Di Martino}, {Maria Teresa} and Nicola Amodio and Eugenio Morelli and Martina Montesano and Cirino Botta and Francesca Scionti and Daniela Talarico and Emanuela Altomare and {Gallo Cantafio}, {Maria Eugenia} and Valeria Zuccal{\`a} and Lorenza Maltese and Katia Todoerti and Marco Rossi and Mariamena Arbitrio and Antonino Neri and Pierosandro Tagliaferri and Pierfrancesco Tassone",
year = "2019",
doi = "10.1038/s41375-018-0238-2",
language = "English",
volume = "33",
pages = "487--498",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - miR-22 suppresses DNA ligase III addiction in multiple myeloma

AU - Caracciolo, Daniele

AU - Di Martino, Maria Teresa

AU - Amodio, Nicola

AU - Morelli, Eugenio

AU - Montesano, Martina

AU - Botta, Cirino

AU - Scionti, Francesca

AU - Talarico, Daniela

AU - Altomare, Emanuela

AU - Gallo Cantafio, Maria Eugenia

AU - Zuccalà, Valeria

AU - Maltese, Lorenza

AU - Todoerti, Katia

AU - Rossi, Marco

AU - Arbitrio, Mariamena

AU - Neri, Antonino

AU - Tagliaferri, Pierosandro

AU - Tassone, Pierfrancesco

PY - 2019

Y1 - 2019

N2 - Multiple myeloma (MM) is a hematologic malignancy characterized by high genomic instability. Here we provide evidence that hyper-activation of DNA ligase III (LIG3) is crucial for genomic instability and survival of MM cells. LIG3 mRNA expression in MM patients correlates with shorter survival and even increases with more advanced stage of disease. Knockdown of LIG3 impairs MM cells viability in vitro and in vivo, suggesting that neoplastic plasmacells are dependent on LIG3-driven repair. To investigate the mechanisms involved in LIG3 expression, we investigated the post-transcriptional regulation. We identified miR-22-3p as effective negative regulator of LIG3 in MM. Enforced expression of miR-22 in MM cells downregulated LIG3 protein, which in turn increased DNA damage inhibiting in vitro and in vivo cell growth. Taken together, our findings demonstrate that myeloma cells are addicted to LIG3, which can be effectively inhibited by miR-22, promoting a novel axis of genome stability regulation.

AB - Multiple myeloma (MM) is a hematologic malignancy characterized by high genomic instability. Here we provide evidence that hyper-activation of DNA ligase III (LIG3) is crucial for genomic instability and survival of MM cells. LIG3 mRNA expression in MM patients correlates with shorter survival and even increases with more advanced stage of disease. Knockdown of LIG3 impairs MM cells viability in vitro and in vivo, suggesting that neoplastic plasmacells are dependent on LIG3-driven repair. To investigate the mechanisms involved in LIG3 expression, we investigated the post-transcriptional regulation. We identified miR-22-3p as effective negative regulator of LIG3 in MM. Enforced expression of miR-22 in MM cells downregulated LIG3 protein, which in turn increased DNA damage inhibiting in vitro and in vivo cell growth. Taken together, our findings demonstrate that myeloma cells are addicted to LIG3, which can be effectively inhibited by miR-22, promoting a novel axis of genome stability regulation.

UR - http://www.scopus.com/inward/record.url?scp=85052535560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052535560&partnerID=8YFLogxK

U2 - 10.1038/s41375-018-0238-2

DO - 10.1038/s41375-018-0238-2

M3 - Article

AN - SCOPUS:85052535560

VL - 33

SP - 487

EP - 498

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 2

ER -